Basilea Pharmaceutica Ltd
(XSWX:BSLN)
CHF
53.1
-1.6 (-2.93%)
Market Cap: 657.20 Mil
Enterprise Value: 586.62 Mil
PE Ratio: 16.91
PB Ratio: 5.11
GF Score: 59/100 Basilea Pharmaceutica Ltd (XSWX:BSLN) Transcripts
- 1